Clene (CLNN)
3.85
-0.14 (3.51%)
Upcoming Events
Latest Headlines
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
August 18, 2026 7:00 AM - Globe NewsWire
Clene to Present at the Emerging Growth Conference
August 17, 2026 8:30 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Clene, Inc. (CLNN)
August 17, 2026 6:51 AM - StreetInsider
Form SCHEDULE 13G/A Clene Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
August 14, 2026 3:55 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: Kiernan Matthew
August 14, 2026 3:33 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: Desai Arjun JJ
August 14, 2026 3:32 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: Mosca Alison
August 14, 2026 3:31 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: MATLIN DAVID J
August 14, 2026 3:31 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: Jacobovitz Shalom
August 14, 2026 3:30 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: Gay Jonathon
August 14, 2026 3:29 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: McLaughlin Vallerie
August 14, 2026 3:28 PM - SEC Filing
Form 4 Clene Inc. For: Aug 13 Filed by: WILCOX REED N
August 14, 2026 3:27 PM - SEC Filing
Form 8-K Clene Inc. For: Aug 14
August 14, 2026 8:35 AM - SEC Filing
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
August 14, 2026 8:30 AM - Globe NewsWire
Form 10-Q Clene Inc. For: Jun 30
August 14, 2026 8:02 AM - SEC Filing
Form SCHEDULE 13G/A Clene Inc. Filed by: Ugwumba Chidozie
August 11, 2026 10:28 AM - SEC Filing
Form 8-K Clene Inc. For: Aug 10
August 10, 2026 8:08 AM - SEC Filing
Clene to include ALS biomarker data in NDA for accelerated approval
August 10, 2026 8:01 AM - StreetInsider
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
August 10, 2026 8:00 AM - Globe NewsWire
Form 4 Clene Inc. For: Jul 17 Filed by: Ugwumba Chidozie
August 6, 2026 1:32 PM - SEC Filing
Form SCHEDULE 13G Clene Inc. Filed by: Empery Asset Management, LP
August 4, 2026 10:09 AM - SEC Filing
Clene to Present at The Canaccord 46th Annual Growth Conference
July 29, 2026 8:30 AM - Globe NewsWire
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026 8:30 AM - StreetInsider
Form 4 Clene Inc. For: Jun 11 Filed by: Mortenson Mark
June 15, 2026 2:24 PM - SEC Filing
Form 4 Clene Inc. For: Jun 11 Filed by: Etherington Robert Dee
June 15, 2026 2:23 PM - SEC Filing
Form 4 Clene Inc. For: Jun 11 Filed by: BROWN MORGAN R
June 15, 2026 2:23 PM - SEC Filing
Full Article List
